Clinical Trial Update: The Effects of Vitamin D and Bone Loss in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 completed trial evaluating whether vitamin D supplementation reduces bone loss in people with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Memorial Medical Center | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED